StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) stock

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$11.14−0.16 (-1.42%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

NovoCure EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

NovoCure's EV/EBITDA was 446.8× on Oct 29, 2021, against 759.2× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Oct 29, 2021446.8×−182.4
2020Dec 31, 2020629.1×–

More NovoCure figures

See a number that looks wrong?